Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method.
El-Abasawy, N., Sharaf El-din, M., EL-Olemy, A., Fouad, A. (2023). Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method.. EKB Journal Management System, 2(1), 1-10. doi: 10.21608/odr.2022.170000.1018
Nasr M. El-Abasawy; Mohamed M. Sharaf El-din; Ahmed EL-Olemy; Ali Fouad. "Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method.". EKB Journal Management System, 2, 1, 2023, 1-10. doi: 10.21608/odr.2022.170000.1018
El-Abasawy, N., Sharaf El-din, M., EL-Olemy, A., Fouad, A. (2023). 'Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method.', EKB Journal Management System, 2(1), pp. 1-10. doi: 10.21608/odr.2022.170000.1018
El-Abasawy, N., Sharaf El-din, M., EL-Olemy, A., Fouad, A. Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method.. EKB Journal Management System, 2023; 2(1): 1-10. doi: 10.21608/odr.2022.170000.1018

Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method.

Octahedron Drug Research
Volume 2, Issue 1, January 2023, Page 1-10  XML PDF (531.79 K)
Document Type: Research Articles
DOI: 10.21608/odr.2022.170000.1018
View on SCiNiTO View on SCiNiTO
Authors
Nasr M. El-Abasawy1; Mohamed M. Sharaf El-dinorcid 1; Ahmed EL-Olemy2; Ali Fouad email orcid 2
1Department of analytical chemistry, College of Pharmacy, Al-Azhar University, Cairo, Egypt
2Pharmaceutical chemistry department, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt
Abstract
A recent, sensitive, stability-indicating RP-HPLC method was used and applied for the simultaneous quantitation of alogliptin benzoate and pioglitazone hydrochloride in their dosage form. Stability tests were done through application of stress conditions on the analyte's solution. Resolution of the drugs was achieved on BDS C18 Column (250x 4.6 mm) and the mobile phase consisted of sodium phosphate pH 3.6, and acetonitrile (60:40; v/v). The flow rate was 1 ml/min and the detector was set at 271 nm. The analytical method was tested for Linearity, accuracy, specificity, precision, ruggedness and robustness. The described HPLC method is valid for quantitation of alogliptin benzoate and Pioglitazone HCl in Tablets and valid as stability indicating method.

The study concerned with the analytical method described for determination of alogliptin benzoate and Pioglitazone HCl in Tablets. The analytical method was tested for Linearity, accuracy, precision, specificity, ruggedness and robustness.

Key words: HPLC, alogliptin, pioglitazone, Stability tests
Keywords
Key words: HPLC; alogliptin; pioglitazone; Stability tests
Statistics
Article View: 323
PDF Download: 341